Xarelto Evidence in Real Life of Patients Preference and Satisfaction Study

Trial Profile

Xarelto Evidence in Real Life of Patients Preference and Satisfaction Study

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 16 Oct 2017

At a glance

  • Drugs Rivaroxaban (Primary)
  • Indications Atrial fibrillation
  • Focus Therapeutic Use
  • Acronyms X-PRESS
  • Sponsors Bayer
  • Most Recent Events

    • 11 Oct 2017 Planned primary completion date changed from 31 Dec 2017 to 30 Jan 2018.
    • 11 Oct 2017 Status changed from recruiting to active, no longer recruiting.
    • 16 Mar 2017 Planned End Date changed from 1 Mar 2018 to 31 Mar 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top